Skip to main content
PROTEOME SCIENCES PLC logo

PROTEOME SCIENCES PLC — Investor Relations & Filings

Ticker · PRM ISIN · GB0003104196 LEI · 213800Q62ICXANKU2986 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2022-08-03 Regulatory Filings
Country GB United Kingdom
Listing IL PRM

About PROTEOME SCIENCES PLC

https://www.proteomics.com/

Proteome Sciences PLC is a specialized Contract Research Organization (CRO) focused on applied proteomics and peptidomics. The company provides comprehensive mass spectrometry-based analytical services to support drug discovery, development, and biomarker identification for precision medicine. Its services cover the full workflow from sample preparation and proteome characterization to bioinformatics data interpretation and reporting, handling diverse biological samples. A key offering is its proprietary TMT® and TMTpro® isobaric tags, which the company invented, developed, and exclusively manufactures for multiplexed protein quantification. These reagents are distributed globally to the mass spectrometry community. The company serves the biopharmaceutical sector, operating under ISO 9001:2015 and Good Clinical Laboratory Practice (GCLP) standards for its targeted assays.

Recent filings

Filing Released Lang Actions
Milestone towards Single Cell Proteomics services
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 6832U' and is dated '03 August 2022'. It contains a brief announcement about a company milestone ('Proteome Sciences completes milestone towards launch of Single Cell Proteomics services') and provides contact information and boilerplate text typical of regulatory news services. The document length is short (4827 chars) and it is clearly a general regulatory announcement rather than a comprehensive financial report (like 10-K or IR) or a specific filing type like a Director's Dealing or Proxy Statement. Since it is a general regulatory announcement distributed via RNS, and it doesn't fit neatly into the other specific categories, the most appropriate classification is the general Regulatory Filings category (RNS).
2022-08-03 English
Change of Registered Office
Regulatory Filings Classification · 1% confidence The document is very short (2635 characters) and announces a minor administrative change: the 'Change of Registered Office' for Proteome Sciences PLC. It is formatted as a standard regulatory news service (RNS) announcement, indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the London Stock Exchange. Since this is a general, non-financial, non-periodic announcement that doesn't fit specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), it falls best under the general regulatory announcement category.
2022-05-26 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states 'Result of Annual General Meeting (AGM)' and confirms that 'all resolutions were duly passed' at the AGM. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, or in this case, the results thereof. Although it is a short announcement, the content is specific to the AGM outcome, making AGM-R a better fit than the general RPA or RNS.
2022-05-16 English
AGM Statement
AGM Information Classification · 1% confidence The document explicitly states it is an "Annual General Meeting (AGM) Statement" being delivered by the Chairman at the AGM. It contains a summary of the company's performance for the year ended 31 December 2021, which is typical content for an AGM address. This directly aligns with the definition for AGM Information (AGM-R). Although it mentions financial performance, it is presented as a statement made during the meeting, not the formal Annual Report (10-K) or an Earnings Release (ER). The document is short and appears to be the text of the statement itself, not just an announcement of a meeting.
2022-05-16 English
Substantial Contract Win
Regulatory Filings Classification · 1% confidence The document is a short announcement released via RNS (Regulatory News Service) from Proteome Sciences PLC, dated May 12, 2022. It announces a 'Substantial contract win' valued over £0.5m. This type of announcement, detailing a significant business event (a contract win) and released through a formal news service (RNS) without being a full financial report (like 10-K or IR), fits best under the general category for miscellaneous regulatory announcements or news releases that don't fit a more specific financial reporting code. Since it is a specific business update released via the official channel, it is classified as a Regulatory Filing (RNS), which serves as the general regulatory announcement fallback.
2022-05-12 English
Director/PDMR Shareholding
Major Shareholding Notification Classification · 1% confidence The document is identified by the 'RNS Number' header and contains specific details about a transaction involving a Director/PDMR (Martin Diggle) purchasing shares of the company (Proteome Sciences PLC). This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing. The filing explicitly mentions compliance with Market Abuse regulations and details the purchase price, volume, and resulting shareholding percentage. This fits the 'Director's Dealing' category (DIRS) better than the general 'Regulatory Filings' (RNS) or 'Major Shareholding Notification' (MRQ), as it focuses specifically on insider transactions.
2022-04-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.